Market Overview

420 Investor Alan Brochstein Tells Benzinga Citron Research Is 'Off-Base' In Most Of Its Attack On Cronos Group, There's No 'Deception' In His View, But Does Agree That The Stock Is Too Expensive


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for CRON

Aug 2018Canaccord GenuityUpgradesSellHold

View More Analyst Ratings for CRON
View the Latest Analyst Ratings

Posted-In: Citron ResearchAnalyst Color Cannabis Short Sellers Exclusives Markets Analyst Ratings Trading Ideas


Related Articles (CRON)

Bank Of America Downgrades KB Financial On Weaker EPS Momentum

Binance Coin: Key To The Binance Exchange Liquidity And Profit Sharing